360 related articles for article (PubMed ID: 16296785)
1. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
Attar M; Shen J; Ling KH; Tang-Liu D
Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
[TBL] [Abstract][Full Text] [Related]
2. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
3. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of ocular drug penetration.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
[TBL] [Abstract][Full Text] [Related]
6. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Del Amo EM; Urtti A
Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
9. Microdialysis assessment of drug delivery systems for vitreoretinal targets.
Duvvuri S; Rittenhouse KD; Mitra AK
Adv Drug Deliv Rev; 2005 Dec; 57(14):2080-91. PubMed ID: 16271800
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic drug delivery: development and regulatory considerations.
Novack GD
Clin Pharmacol Ther; 2009 May; 85(5):539-43. PubMed ID: 19225448
[No Abstract] [Full Text] [Related]
12. Aqueous formulations and ointments.
MacKeen DL
Int Ophthalmol Clin; 1980; 20(3):79-92. PubMed ID: 6998903
[TBL] [Abstract][Full Text] [Related]
13. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
[TBL] [Abstract][Full Text] [Related]
14. Contact lenses for drug delivery.
Ciolino JB; Dohlman CH; Kohane DS
Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
[TBL] [Abstract][Full Text] [Related]
15. Barriers to glaucoma drug delivery.
Ghate D; Edelhauser HF
J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
[TBL] [Abstract][Full Text] [Related]
16. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
Tashakori-Sabzevar F; Mohajeri SA
Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
[TBL] [Abstract][Full Text] [Related]
17. Iontophoresis: a non-invasive ocular drug delivery.
Eljarrat-Binstock E; Domb AJ
J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
[TBL] [Abstract][Full Text] [Related]
18. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation.
Hosoya K; Lee VH; Kim KJ
Eur J Pharm Biopharm; 2005 Jul; 60(2):227-40. PubMed ID: 15939235
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery systems for the eye.
Kearns VR; Williams RL
Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
[TBL] [Abstract][Full Text] [Related]
20. Basic ocular pharmacotherapy.
O'Brien TP; Reynolds LA
J Ophthalmic Nurs Technol; 1995; 14(4):160-4. PubMed ID: 7650747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
